Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Cell 165 , 16321643 (2016)
Navigating GLP-1 care with Maven Clinic At Maven Clinic, we build a personalized care plan around how your body works
Its safety comes from its biochemistry, not from marketing claims about naturalness
The adverse reactions that occurred in at least two (6.1%) REPATHA-treated patients, and more frequently than in placebo-treated patients, included: Upper respiratory tract infection (9.1% versus 6.3%) Influenza (9.1% versus 0%) Gastroenteritis (6.1% versus 0%) Nasopharyngitis (6.1% versus 0%) In a multicenter, open-label 5-year extension study, 106 patients with HoFH, including 14 pediatric patients, received 420 mg of REPATHA subcutaneously once monthly or every 2 weeks [see Clinical Studies (14)]
US$ 25.94
US$ 26.21
US$ 23.15
US$ 29.00
.tmb-media470.png?Culture=en&sfvrsn=f906983b_3)
